01 1Biocon Biologics Limited
01 1Insulin glargine (gene recombination)
01 1India
Insulin glargine (genetical recombination)
Registration Number : 226MF10213
Registrant's Address : Biocon House, Ground Floor, Tower-3, Semicon Park, Electronic City, Phase-II, Hosur R...
Initial Date of Registration : 2014-11-17
Latest Date of Registration : 2019-01-24
79
PharmaCompass offers a list of Insulin Glargine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Insulin Glargine manufacturer or Insulin Glargine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Insulin Glargine manufacturer or Insulin Glargine supplier.
PharmaCompass also assists you with knowing the Insulin Glargine API Price utilized in the formulation of products. Insulin Glargine API Price is not always fixed or binding as the Insulin Glargine Price is obtained through a variety of data sources. The Insulin Glargine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Insulin Glargine-aglr manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Insulin Glargine-aglr, including repackagers and relabelers. The FDA regulates Insulin Glargine-aglr manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Insulin Glargine-aglr API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Insulin Glargine-aglr manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Insulin Glargine-aglr supplier is an individual or a company that provides Insulin Glargine-aglr active pharmaceutical ingredient (API) or Insulin Glargine-aglr finished formulations upon request. The Insulin Glargine-aglr suppliers may include Insulin Glargine-aglr API manufacturers, exporters, distributors and traders.
click here to find a list of Insulin Glargine-aglr suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Insulin Glargine-aglr Drug Master File in Japan (Insulin Glargine-aglr JDMF) empowers Insulin Glargine-aglr API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Insulin Glargine-aglr JDMF during the approval evaluation for pharmaceutical products. At the time of Insulin Glargine-aglr JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Insulin Glargine-aglr suppliers with JDMF on PharmaCompass.
We have 1 companies offering Insulin Glargine-aglr
Get in contact with the supplier of your choice:
